(Q52933848)

9 May 2018

title

'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. (English)

1 reference

9 May 2018

0 references

2

1 reference

9 May 2018

Kai-Uwe Eckardt

series ordinal

4

object named as

Eckardt KU

1 reference

9 May 2018

author name string

Lauschke A

series ordinal

1

1 reference

9 May 2018

Frei U

series ordinal

3

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

9 May 2018

published in

Kidney International

1 reference

9 May 2018

volume

69

1 reference

9 May 2018

issue

9

1 reference

9 May 2018

page(s)

1669-1674

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000310

exact match

0 references

cites work

"Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Vascular dopamine receptors: Demonstration and characterization by in vitro studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Is renal dose dopamine protective or therapeutic? Yes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Renal dopamine receptors in health and hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Anatomical distribution and function of dopamine receptors in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Effects of dopamine on renal function in the rat isolated perfused kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

The benefit of low-dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: does it protect renal function?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Effect of "renal-dose" dopamine on renal function following cardiac surgery.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Pulsatility and resistance indices in intrarenal arteries of normal adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Intrarenal Doppler: characteristics of aging kidneys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Practical use of duplex Doppler analysis of the renal vasculature in critically ill patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Renovascular interaction of epinephrine, dopamine, and intraperitoneal sepsis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Regional haemodynamic effects of dopamine and its prodrugs L-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Dopamine clearance in critically ill patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Effect of dopamine on intrapulmonary shunt fraction and oxygen transport in severe sepsis with circulatory and respiratory failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Preconditioning strategies to limit graft immunogenicity and cold ischemic organ injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Adverse effect of donor vasopressor support on immediate and one-year kidney allograft function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000310

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000310

1 reference

9 May 2018

1 reference

9 May 2018